DLX2 and prostate carcinoma: Interestingly, Abnormal expression of DLX2 was found in malignant progression of human solid tumors including gastric adenocarcinoma, acute lymphoblastic leukemia, melanoma, glioma, breast, lung and prostate cancer [30, 32, 34, 38].